San Jose, CA (PRWEB)
May 09, 2013
Theravent, Inc., a private investment group based in San Jose, California, has acquired the assets of Ventus Medical. Theravent, Inc. will offer FDA cleared, Provent Sleep Apnea Therapy, available with a prescription, and over-the-counter Theravent Advanced Nightly Snore Therapy.
"Theravent, Inc. is committed to the uninterrupted and ongoing supply of Provent Sleep Apnea Therapy to patients and clinicians, and expanding the US introduction of Theravent Advanced Snore Therapy" said Matthew Williams, CEO & President of Theravent, Inc. "We’ve already heard from numerous patients and want to assure everyone that Provent Therapy will continue to be available as a treatment option for Obstructive Sleep Apnea (OSA)!”
Mr. Williams adds, “Over 40 million Americans suffer from a sleep disorder, and 20 million from OSA. Nasal EPAP represents a significant advancement in the treatment of sleep related breathing disorders and we are committed to the patients and clinicians using our devices on a nightly basis. We strongly believe in the clinical evidence and clinical importance of Provent Therapy as a treatment option for patients. Our intent is to ensure a continuous supply of Provent for patients and clinicians going forward.”
The company will share updates regarding the transition and the continued operations of the company in the coming weeks. Additional information on Theravent Advanced Nightly Snore Therapy and Provent Sleep Apnea Therapy, including product reviews, where to purchase, clinical data, and helpful snore and sleep apnea resources are available at theravent.com and proventtherapy.com.